health pharma news today obesity drugs glp-1 Once people understood glucagonlike peptide 1 (GLP-1) drugs' potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 Chart: 1 in 8 Americans

Since that time more than 800k activations were made and 234 MEUR spent (as of 2024)

As GLP-1 treatments become more mainstream and accessible, gyms, fast food companies and other fitness and wellness brands are offering programs and products to support those using weight loss drugs

WHO Guidelines on Physical Activity and Sedentary Behavior

INTRODUCTION The incretin hormones secreted by L cells in the ileum and colon are GLP-1 receptor agonists (RAs) [3]

Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis